These are generally milder than the nausea, vomiting, and digestive issues commonly associated with pharmaceutical GLP-1 medications
To view or add a comment, sign in Glucagon-Like Peptide-1 Receptor Agonists in Cardiovascular-Kidney-Metabolic Syndrome: Integrated Clinical Benefits Cardiovascular-kidney-metabolic (CKM) syndrome reflects the convergence of cardiovascular disease, chronic kidney disease, obesity, and diabetes, conditions that frequently coexist and amplify long-term morbidity and mortality
PlexusDx's graduated dosing protocol reduces severe nausea by 40-50% compared to rapid escalation protocols, allowing your body to adapt
These drugs mimic natural gut hormones to slow digestion, reduce appetite, and improve blood sugar control
If possible, work with your provider to taper your dose gradually rather than stopping cold